Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of idursulfase beta in Chinese children with mucopolysaccharidosis II
CTR20263035Phase 4Active
- Sponsor
- GC Biopharma
- Start
- Aug 2026
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Idursulfase beta in mucopolysaccharidosis type 2, sponsored by GC Biopharma. Started Aug 2026; status: active.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on CTR20263035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263035.